Compare
Amgen vs Gilead Sciences (AMGN vs GILD)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Amgen (AMGN) returned +43.9% and Gilead Sciences (GILD) +36.1%; so far this year the figures are +40.7% and +36.0%.
Amgen is the larger company by market value, about 1.2 times the size of Gilead Sciences.
Revenue grew +8.2% at AMGN and +6.5% at GILD over the last year.
AMGN yields 2.16%. GILD yields 1.95%.
Data as of the latest close. Not investment advice.
Relative performance
| AMGN | GILD | |
|---|---|---|
| Price | $460.42 | $166.89 |
| 1-day | +0.03% | -0.41% |
| YTD | +40.67% | +35.97% |
| 1 year | +43.94% | +36.15% |
| 3 years | +76.51% | +108.12% |
| Market cap | $249.1B | $207.0B |
| P/E | 26.7 | — |
| P/S | 6.40 | 6.68 |
| P/B | 17.35 | 15.87 |
| Revenue growth | +8.20% | +6.50% |
| EPS growth | +33.30% | -149.00% |
| Gross margin % | 70.9 | 79.9 |
| Net margin % | 24.1 | -12.5 |
| ROE % | 65.4 | -29.6 |
| Debt / equity | 3.76 | 2.01 |
| FCF yield % | 3.8 | 6.7 |
| Dividend yield % | 2.16 | 1.95 |
| Beta | 0.50 | 0.37 |
| RSI (14) | 60.5 | 60.2 |
| Technical rating |